Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3(2) Factorial Design to Improve Solubility and In Vitro Bioavailability

Piroxicam is a Biopharmaceutical Classification System (BCS) Class II drug having poor aqueous solubility and a short half-life. The rationale behind the present research was to develop a Piroxicam nanosuspension to enhance the solubility and thereby the in vitro bioavailability of the drug. Piroxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhamhoom, Yahya, Honmane, Sandip M., Hani, Umme, Osmani, Riyaz Ali M., Kandasamy, Geetha, Vasudevan, Rajalakshimi, Paramshetti, Sharanya, R. Dudhal, Ravindra, K. Kengar, Namrata, Charde, Manoj S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919943/
https://www.ncbi.nlm.nih.gov/pubmed/36771784
http://dx.doi.org/10.3390/polym15030483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919943/
https://www.ncbi.nlm.nih.gov/pubmed/36771784
http://dx.doi.org/10.3390/polym15030483

Ejemplares similares